Liron Shemesh-Darvish

Liron Shemesh-Darvish, Ph.D., MBA, has served as Senior Director, Head of Preclinical Development since March 2021. From June 2019 to December 2020, Dr. Shemesh-Darvish served as Director, Head of Preclinical Development. Dr. Shemesh-Darvish has over 15 years of extensive industry experience in preclinical drug development in global programs. Before joining BioLineRx, from 2018 through 2019, Dr. Shemesh-Darvish served as Director of Toxicology at Salzman Group Ltd. and before that, served for 12 years as Senior Manager, Non-clinical Leader and Senior Researcher of Method Development in a number of positions in the global R&D division at Teva Pharmaceutical Industries Ltd. Dr. Shemesh-Darvish holds a Ph.D. in biology and MBA, both from Bar-Ilan University in Israel.